Optimization of somatotropin dose during treatment of children before puberty with the syndrome of bioinactive growth hormone

Abstract

Objective — to study effectiveness and safety of applying various doses of recombinant growth hormone (rGH) during treatment of children before puberty with the syndrome of bioinactive growth hormone (SBGH) in order to improve their eventual growth. Materials and methods. We have examined 93 children before puberty, aged 3 to 10 years, afflicted with SBGH. In all children there has been found a growth retardation exceeding 2 standard deviations (SD) from physiological parameters. For the purpose of differential diagnostics of SBGH and determination of sensitivity to rGH we were using four­day test with growth hormone. Treatment of all patients with rGH begun with a 0.03 mg/kg/day dose. The control group consisted of 48 children before puberty with pituitary dwarfism. Results and discussion. In the main group we identified smaller growth effect than in the control group. Significant difference between growth gain in the main group and in the control group was determined since 6th month of rGH treatment and was there until the end of 12th month in case of hormone usage. In children with unsatisfactory growth gain the rGH dose was increased to 0.035 mg/kg/day; in case of further insufficiency of growth rate the rGH dose was increased to 0.05 mg/kg/day. After 12 months of treatment with various doses of rGH the optimal growth effect has been achieved in the subgroup of children with an rGH dose of 0.05 mg/kg/day. Conclusions. Optimally the treatment of patients with SBGH should be started with rGH dose of 0.035 mg/kg/day; in case of unsatisfactory effect after 3–6 months it is recommended to increase rGH dose to 0.05 mg/kg/day.

Authors and Affiliations

N. A. Sprynchuk, Yu. I. Belyakova

Keywords

Related Articles

Impact of celiac disease and symptomatic hypothyroidism on progression of type 1 diabetes in children: literature review and researchers’ own observation

It is not uncommon for type 1 diabetes to run concurrently with endocrine and non-endocrine immunopathological diseases. The most prevalent of those are thyroid gland diseases and celiac disease. A combination of several...

Physical development as an integral indicator of rehabilitation of patients with type 1 diabetes mellitus

The objective of the study was to determine the characteristics of physical development of adolescents with type 1 diabetes mellitus, in the current conditions of medical care. Materials and methods. A comprehensive sur...

Characteristics of clinical picture, diagnosis and treatment of Cushing’s disease in children

In children Cushing’s disease is rare. Growth prognosis, adequacy of development of peak bone mass, development of metabolic complications of the disease all depend on timeliness of diagnosis and treatment. Presented in...

Characteristics of physical development of school-age children affected by the armed conflict in eastern Ukraine

Objective — to determine characteristics of disorders in physical development (PD) of school-age children affected by the armed conflict in eastern Ukraine. Materials and methods. We assessed the nature of PD of childre...

Relationship between blood dopamine level, behavioral and emotional status of puberty-age children with obesity and normal body mass

Objective — to study the relationship between blood dopamine level, emotional and behavioral status depending on body mass index (BMI), sex and puberty stage in children with obesity and normal body mass; to identify ris...

Download PDF file
  • EP ID EP292834
  • DOI -
  • Views 130
  • Downloads 0

How To Cite

N. A. Sprynchuk, Yu. I. Belyakova (2018). Optimization of somatotropin dose during treatment of children before puberty with the syndrome of bioinactive growth hormone. Український журнал дитячої ендокринології, 0(1), 40-44. https://europub.co.uk./articles/-A-292834